Sep 10, 2026 09:00AM
Aug 13, 2026 09:31AM
Aug 13, 2026 09:30AM
Aug 6, 2026 11:34AM
Aug 6, 2026 11:29AM
Jul 22, 2026 08:30AM
Jul 6, 2026 08:45AM NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
Jun 29, 2026 09:30AM
Jun 29, 2026 09:30AM
Jun 25, 2026 09:20AM
Jun 25, 2026 09:20AM
Jun 22, 2026 09:00AM
Jun 11, 2026 09:02AM
Jun 11, 2026 09:00AM NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
Jun 9, 2026 09:01AM
Jun 9, 2026 09:00AM
Apr 6, 2026 09:20AM
Apr 6, 2026 09:20AM
Mar 31, 2026 09:20AM
Mar 24, 2026 09:03AM
Mar 24, 2026 09:00AM NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout
Mar 18, 2026 08:00AM
Mar 16, 2026 11:34AM
Mar 16, 2026 11:33AM
Mar 9, 2026 11:07AM
Feb 18, 2026 09:05AM
Feb 18, 2026 09:05AM
Feb 9, 2026 09:20AM NeuroSense receives Australian patent for PrimeC drug composition
Feb 9, 2026 09:20AM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Jan 8, 2026 08:45AM
Dec 22, 2025 09:18AM
Dec 22, 2025 09:17AM
Dec 4, 2025 07:30AM NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026
Nov 24, 2025 09:56AM
Nov 24, 2025 09:56AM
Oct 6, 2025 09:00AM
Sep 10, 2025 02:30PM
Sep 4, 2025 08:49AM
Sep 4, 2025 08:49AM
Aug 1, 2025 09:00AM NeuroSense Provides Business Update and Progress for the First Half of 2025
Jul 22, 2025 08:42AM
Apr 24, 2025 09:09AM
Apr 24, 2025 09:09AM
Apr 9, 2025 08:30AM
Apr 9, 2025 08:30AM
Apr 7, 2025 05:14PM
Apr 4, 2025 09:10AM NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
Mar 20, 2025 10:30AM

330,739 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All